Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$25M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 4 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 10 most recent Form 4 transactions.
| BlossomHill Therapeutics,… |
| PBUY |
| 625,000 |
| $16.00 |
| $10M |
| +29.9% |
| Open the original filing on SEC.gov |
| Aug 10 | BLSM | BlossomHill Therapeutics,… | CCONV | 1M | — | — | +100.9% | Open the original filing on SEC.gov |
| Aug 10 | BLSM | BlossomHill Therapeutics,… | CCONV | 1M | — | — | — | Open the original filing on SEC.gov |
| Aug 6 | BLSM | BlossomHill Therapeutics,… | AGRANT◆ | 23,904 | — | — | — | Open the original filing on SEC.gov |
| Jul 27 | SCTX | Scribe Therapeutics, Inc. | CCONV◆ | 2.1M | — | — | — | Open the original filing on SEC.gov |
| Jul 27 | SCTX | Scribe Therapeutics, Inc. | PBUY | 1M | $15.00 | $15M | +286.7% | Open the original filing on SEC.gov |
| Jul 27 | SCTX | Scribe Therapeutics, Inc. | CCONV | 348,825 | — | — | — | Open the original filing on SEC.gov |
| Jul 23 | SCTX | Scribe Therapeutics, Inc. | AGRANT◆ | 14,725 | — | — | — | Open the original filing on SEC.gov |